Nuclear Antidote Range

Potassium Iodide (KI) — Manufacturer & Supplier

USP | BP | IP Grades Available | WHO-GMP Certified | Bulk Institutional Supply

Potassium Iodide (KI) is a critical nuclear countermeasure used to protect the thyroid gland from radioactive iodine exposure. Golden Hour Pharma supplies pharmaceutical-grade KI tablets and oral solutions to governments, defence organisations, hospitals, and national stockpile programmes across Africa, MENA, and Latin America.

Product Overview

What Is Potassium Iodide (KI)?

Potassium Iodide (KI) is a stable, non-radioactive salt of iodine with the chemical formula KI. It is classified as an essential medicine by the World Health Organization (WHO) and is included on the WHO Model List of Essential Medicines for its role in thyroid protection during nuclear and radiological emergencies. The U.S. Food and Drug Administration (FDA) has approved KI as a thyroid blocking agent for use in radiation emergencies involving the release of radioactive iodine.

In pharmaceutical form, KI is available as scored tablets (65 mg and 130 mg strengths) and as an oral solution. It is manufactured under strict Good Manufacturing Practice (GMP) conditions and supplied in compliance with USP, BP, and IP pharmacopoeia standards. The compound has a well-established safety and efficacy profile, with decades of clinical and public health use supporting its role in nuclear emergency preparedness.

KI is procured by national health authorities, defence organisations, nuclear regulatory agencies, hospital pharmacies, and emergency preparedness programmes. It forms a core component of nuclear countermeasure stockpiles alongside other agents such as Prussian Blue for radioactive caesium exposure and Potassium Iodate (KIO3).

How Potassium Iodide Protects Against Radioiodine Exposure

When a nuclear event releases radioactive iodine (primarily Iodine-131) into the environment, the thyroid gland absorbs it rapidly because the thyroid cannot distinguish between radioactive and stable iodine. This uptake can lead to thyroid cancer and other thyroid disorders, particularly in children and young adults. Potassium Iodide works through a mechanism known as thyroid blocking: by saturating the thyroid gland with stable iodine before or shortly after exposure, KI prevents the gland from absorbing the radioactive isotope.

The effectiveness of KI is time-dependent. The WHO recommends administration prior to exposure or as soon as possible within the first 24 hours following exposure for maximum protective effect. Pre-exposure dosing provides near-complete thyroid blocking, while administration within 2 hours of exposure still offers approximately 80% protection. Beyond 24 hours, efficacy diminishes significantly.

WHO Recommendation

The World Health Organization recommends that countries with nuclear power installations or those within range of potential cross-border radiological exposure maintain national stockpiles of Potassium Iodide for rapid distribution to at-risk populations. Strategic pre-positioning of KI in hospitals, emergency centres, and community distribution points is considered a best practice in nuclear emergency preparedness planning.

Product Specifications

Available Grades and Specifications

Grade
Form
Strengths
Packaging Options
USP
Tablet
65 mg, 130 mg
Blister packs, bulk bottles, institutional drums
BP
Tablet
65 mg, 130 mg
Blister packs, bulk bottles, institutional drums
IP
Tablet
65 mg, 130 mg
Blister packs, bulk bottles, institutional drums
USP / BP
Oral Solution
65 mg/mL
Unit-dose vials, bulk containers

Custom labelling, government-specification packaging, and alternative pack sizes are available on inquiry. Contact our team to discuss your specific requirements.

Quality Standards

Quality Assurance and Compliance

WHO-GMP Certified Manufacturing

All Potassium Iodide supplied by Golden Hour Pharma is manufactured in WHO-GMP certified facilities that undergo regular inspection and validation. Our manufacturing partners maintain current Good Manufacturing Practice compliance across every stage of production.

Batch Validation & Full Traceability

Every batch of KI undergoes rigorous in-process and finished-product testing. Full batch traceability from raw material sourcing through to final release ensures complete accountability. Certificate of Analysis (CoA) is provided with every shipment upon request.

Multi-Standard Regulatory Alignment

Our KI products are manufactured in alignment with USFDA, EU-GMP, and Health Canada regulatory frameworks. This multi-standard compliance enables procurement by institutions operating under diverse regulatory requirements across global markets.

Documentation & Regulatory Support

We provide comprehensive regulatory documentation including Certificates of Analysis, product dossiers, stability data, and pharmacopoeia compliance certificates to support your procurement and registration processes.

Procurement

How to Procure Potassium Iodide Through Golden Hour Pharma

Our streamlined procurement process is designed to reduce complexity and deliver pharmaceutical-grade KI with full documentation and regulatory support. Institutional pricing and minimum order quantities are available on request.

Step 01

Submit Inquiry

Share your requirements including grade, strength, volume, packaging preferences, and delivery destination through our inquiry form.

Step 02

Specification Review

Our pharmaceutical team reviews your specifications, confirms grade availability, and aligns product documentation with your regulatory requirements.

Step 03

Quote & Lead Time

Receive a detailed quotation with institutional pricing, minimum order quantities, and confirmed lead times based on your volume and destination.

Step 04

Delivery & Documentation

Coordinated shipment with full batch documentation, Certificate of Analysis, and regulatory paperwork delivered alongside your consignment.

FAQ

Frequently Asked Questions

What is the difference between Potassium Iodide and Potassium Iodate?

Both Potassium Iodide (KI) and Potassium Iodate (KIO3) are stable iodine compounds used for thyroid blocking in nuclear emergencies. KI is more widely referenced in FDA and WHO guidelines, while KIO3 offers superior stability in tropical climates and is preferred in several national stockpile programmes. Both are effective thyroid blocking agents when administered at the correct dosage. Learn more about Potassium Iodate (KIO3)

What pharmacopoeia grades do you supply?

We supply Potassium Iodide tablets and oral solution in USP (United States Pharmacopeia), BP (British Pharmacopoeia), and IP (Indian Pharmacopoeia) grades. Specific grade requirements can be confirmed at the time of inquiry to ensure alignment with your regulatory and procurement standards.

Can you supply with custom labelling for national stockpile programmes?

Yes. We offer custom labelling, packaging, and branding options tailored to national stockpile requirements, government distribution programmes, and institutional procurement mandates. Contact our team to discuss your specific labelling and packaging needs.

What is the typical shelf life?

Potassium Iodide tablets supplied by Golden Hour Pharma carry a shelf life of 5 years from the date of manufacture, when stored under recommended conditions (below 25 degrees Celsius, protected from light and moisture). Stability data and storage guidelines are provided with every shipment.

Do you supply in bulk for government programmes?

Yes. Golden Hour Pharma actively supports government and institutional procurement programmes across Africa, MENA, and Latin America. We accommodate large-volume orders with competitive institutional pricing, flexible packaging, and coordinated logistics for national distribution.

Submit a Potassium Iodide Procurement Inquiry

Whether you are building a national stockpile, equipping a hospital pharmacy, or securing supply for a defence programme, our team is ready to support your Potassium Iodide procurement with pharmaceutical-grade product and full regulatory documentation.